Vaccine comprising il-13 and an adjuvant
CA 2496607 A1 · Owner: Ashman, Claire · Inventors: Ellis, Jonathan Henry; Ashman, Claire
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to IL-13 vaccines and their use in the treatment of diseases that are treatable with neutralisation of IL-13 such as COPD, asthma and atopic disorders such as hayfever contact allergies and atopic , dermatitis. The vaccines of the present invention comprise an IL-13 immunogen and an adjuvant composition which is a combination of a saponin and an immunostimulatory oligonucleotide comprising at least one unmethylated dinucleotide. The invention further relates to pharmaceutical compositions comprising such immunogens and their use in medicine and to methods for their production.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 28, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 28, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 28, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.